Wallerian degeneration: an emerging axon death pathway linking injury and disease
Retatrutide Dosage Safety Considerations Some individuals may experience temporary digestive symptoms when increasing dosage
Summary Microdosing is typically treated as a tolerability-first, clinician-guided approach, involving starts below the usual 2.5 mg step, extending escalation windows from 4 to 8 weeks or more, or pausing at intermediate maintenance doses, such as 5 mg or 7.5 mg, to prioritize steady adherence and symptom control
Researchers documented side effects, established dosage schedules, identified patient populations most likely to benefit, and demonstrated that the medication delivers approximately 15% body weight loss under controlled conditions
The active compounds themselves have been studied extensively